IP Library Granted Patent US 9,980,809
Granted Patent B2
US 9,980,809 · App. 15/456,078 · Granted May 29, 2018

Implantable devices and techniques for oncoplastic surgery

Inventors: Gail S. Lebovic (Frisco, TX); David B. Willis (Mountain View, CA); George D. Hermann (Los Altos Hills, CA); Jonathan M. Olson (San Jose, CA)
Assignee: Focal Therapeutics, Inc.
A61F2/12A61B17/00A61B17/0206A61B2017/008A61F2210/0004A61F2230/0008A61F2230/0091A61F2250/0097A61F2250/0098
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,980,809
App. No.
15/456,078
Granted
May 29, 2018
Kind
B2
Abstract

Described herein are devices for placement in surgically created soft tissue spaces, potential spaces, or cavities. The implantable devices generally include a bioabsorbable body having an open framework that facilitates attachment of tissue thereto in a manner that helps avoid post-surgical deformities. Methods for using the implantable devices in oncoplastic surgery are further described.

Claims (21)

1. A method of reconstituting the contour of a breast after surgical removal of tissue comprising:

placing a device within a cavity or space, the cavity or space formed by the surgical removal of tissue, wherein the device comprises a rigid and entirely bioabsorbable body having a non-contiguous external perimeter surface formed by one or more framework elements, wherein the one or more framework elements provide temporary structural support to the cavity or space and prior to resorption, allow seroma fluid and tissue to pass through the non-contiguous external perimeter surface so that the seroma fluid and tissue can promote tissue regrowth within the body of the device to reconstitute the contour of the breast, and further comprising manipulating the tissue surrounding the device to allow substantial volumes of tissue to be pulled over or under it, or be wrapped around the device in various directions.

2. The method of claim 1 , wherein manipulating the tissue surrounding the device comprises attaching the surrounding tissue to the device.

3. The method of claim 1 , wherein the wrapped tissue is sutured to secure it around the device.

4. The method of claim 2 , wherein attaching the surrounding tissue comprises suturing the tissue to one or more framework elements.

5. The method of claim 1 , wherein the cavity or space is formed by the surgical removal of tumor tissue.

6. The method of claim 1 , wherein the one or more framework elements are mammographically radiolucent.

7. The method of claim 1 , wherein the device comprises a radiographically visible element.

8. The method of claim 1 , wherein the one or more framework elements form a trellis-like framework.

9. The method of claim 1 , wherein placing the device into the cavity or space partially replaces a volume of the surgically removed tissue.

10. The method of claim 1 , further comprising suturing the surrounding tissue through the device.

11. A method of reconstituting the contour of a breast comprising:

placing a device into a cavity or void created by removal of a volume of breast tissue, the device comprising a rigid and entirely bioabsorbable open framework to provide temporary structural support to the cavity or void, wherein the device is sized smaller than the cavity or void; and

manipulating remaining breast tissue surrounding the device, to allow substantial volumes of tissue to be pulled over or under it, or be wrapped around the device in various directions,

wherein prior to resorption, seroma fluid and tissue pass into the device to promote tissue regrowth within the device thereby reconstituting the contour of the breast.

12. The method of claim 11 , wherein manipulating remaining breast tissue comprises attaching tissues within the rigid and entirely bioabsorbable open framework.

13. The method of claim 11 , wherein the cavity or void has minimal overlying tissue.

14. The method of claim 13 , wherein the device has a flattened or low profile shape.

15. The method of claim 11 , wherein the device is sized so that it corresponds to the size of a tumor contained within the removed volume of breast tissue.

16. The method of claim 11 , wherein the rigid and entirely bioabsorbable open framework comprises a trellis-like framework formed from one or more framework elements.

17. The method of claim 11 , wherein the device comprises a radiographically visible element.

Assignments (6)
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 047582/0020 Recorded Apr 24, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., AS SUCCESSOR-BY-MERGER TO FOCAL THERAPEUTICS, INC.
Reel/Frame 075455/0555 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
MERGER AND CHANGE OF NAME Recorded Jul 13, 2021
From: FOCAL THERAPEUTICS, INC.; HOLOGIC, INC.
To: HOLOGIC, INC.
Reel/Frame 056835/0532 →
SECURITY INTEREST Recorded Oct 14, 2019
From: HOLOGIC, INC.; CYNOSURE, LLC; CYTYC CORPORATION; FAXITRON BIOPTICS, LLC; FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 050719/0701 →
SECURITY INTEREST Recorded Nov 26, 2018
From: FOCAL THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047582/0020 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 13, 2017
From: LEBOVIC, GAIL S.; WILLIS, DAVID B.; HERMANN, GEORGE D.; OLSON, JONATHAN M.
To: FOCAL THERAPEUTICS, INC.
Reel/Frame 041562/0910 →
Continuity (3)
Continuation 14808852 · Jul 24, 2015
Provisional Application 62029358 · Jul 25, 2014
Related Publication 20170181845A1 · Jun 29, 2017